Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications

@inproceedings{Chapman2018Alpha1A,
  title={Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications},
  author={Kenneth R Chapman and Joanna Chorostowska-Wynimko and Andreas Rembert Koczulla and Ilaria Ferrarotti and Noel Gerry McElvaney},
  booktitle={International journal of chronic obstructive pulmonary disease},
  year={2018}
}
Alpha 1 antitrypsin deficiency is a hereditary condition characterized by low alpha 1 proteinase inhibitor (also known as alpha 1 antitrypsin [AAT]) serum levels. Reduced levels of AAT allow abnormal degradation of lung tissue, which may ultimately lead to the development of early-onset emphysema. Intravenous infusion of AAT is the only therapeutic option that can be used to maintain levels above the protective threshold. Based on its biochemical efficacy, AAT replacement therapy was approved… CONTINUE READING

Citations

Publications citing this paper.

References

Publications referenced by this paper.
Showing 1-10 of 96 references

The Diagnosis and Management of Alpha-1 Antitrypsin Deficiency in the Adult.

Chronic obstructive pulmonary diseases • 2016
View 4 Excerpts
Highly Influenced

A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy.

American journal of respiratory and critical care medicine • 1999
View 5 Excerpts
Highly Influenced

Cancer risks attributable to low doses of ionizing radiation: assessing what we really know.

Proceedings of the National Academy of Sciences of the United States of America • 2003
View 2 Excerpts
Highly Influenced

Slower lung function decline during augmentation therapy in patients with alpha1-antitrypsin deficiency (A1ATD): results from the Canadian AIR registry

KR Chapman, AC Bradi, D Paterson, RJ Navickis, MM. Wilkes
Proc Am Thorac Soc. 2005;2:A808 • 2018

Biochemical comparison of four commercially available human α1-proteinase inhibitors for treatment of α1-antitrypsin deficiency.

Biologicals : journal of the International Association of Biological Standardization • 2017

Similar Papers

Loading similar papers…